NSIS-B:CPH
Novozymes A/S
DKK 435.10
arrow_upward
+1.68%(+7.20) 1D
Oct 9, 5:00:00 PM GMT+2 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NSIS-B...
Open
DKK 427.80
High
DKK 436.00
Low
DKK 427.80
Mkt. cap
177.38B
Avg. vol.
622.29K
Volume
668.29K
52-wk high
DKK 465.00
52-wk low
DKK 336.80
Shares outstanding
414.56M
No. of employees
11K
Open
DKK 427.80
High
DKK 436.00
Low
DKK 427.80
Mkt. cap
177.38B
Avg. vol.
622.29K
Volume
668.29K
52-wk high
DKK 465.00
52-wk low
DKK 336.80
Shares outstanding
414.56M
No. of employees
11K
News stories
From web sources and news partners
MarketBeat
·
28 minutes ago
Priority Technology Holdings, Inc. (NASDAQ:PRTH) Stock Now Rated "Hold" by Wall Street Analysts
24/7 Wall St.
·
28 minutes ago
Why "VOO and Chill" Lost Money for 8 Straight Years: What $100,000 in the S&P 500 Did From 2000 to 2008
Seeking Alpha
·
37 minutes ago
S&P 500 Index Concentration - Room At The Top
Yahoo Finance
·
2 hours ago
Should Twilio’s (TWLO) Inclusion in the S&P 500 Require Action From Existing Investors?
Profile
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, Greater Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
About Novozymes A/S